To offer you a better experience, this site uses cookies, including those of third parties. To find out more and manage your preferences, consult the cookie policy
Though it may start as an isolated tumor of the eye,
becoming a systemic disease.1
As metastatic UM (mUM) runs its course, treatment options are limited and patients face a median survival of up to 12 months.2 So, when you see mUM, think fast.
Please download the brochure for more information on uveal melanoma.
DownloadThe information contained on this website is intended for healthcare professionals. By clicking the "Continue" button, you are acknowledging that you are a healthcare professional.
The information and other content contained on this website are not intended to be, nor should they be, used as medical advice, diagnosis, or treatment. Each patient must be evaluated, diagnosed, and treated based upon that individual patient's specific circumstances.
Click “Continue” to proceed to an external website not sponsored or controlled by Immunocore.
Select “Cancel” to return to ThinkUvealMelanoma.com.
You will be notified when new information becomes available at ThinkUvealMelanoma.com.
You have been unsubscribed from ThinkUvealMelanoma.com.
Before you leave, will you take a moment to answer five quick questions? Your feedback will help us maintain and improve ThinkUvealMelanoma.com.
We appreciate your taking the time to share your valuable opinion. Your thoughts on ThinkUvealMelanoma.com will help us continually update and enhance the site.